Calcitriol Analogues Decrease Lung Metastasis but Impair Bone Metabolism in Aged Ovariectomized Mice Bearing 4T1 Mammary Gland Tumours.

breast cancer calcitriol elderly metastasis ovariectomized mice vitamin D analogues

Journal

Aging and disease
ISSN: 2152-5250
Titre abrégé: Aging Dis
Pays: United States
ID NLM: 101540533

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 02 08 2018
accepted: 21 09 2018
entrez: 10 10 2019
pubmed: 9 10 2019
medline: 9 10 2019
Statut: epublish

Résumé

Calcitriol and its analogues are considered drugs supporting the anticancer treatment of breast cancer and preventing the osteoporosis that results from the development of cancer or from chemotherapy or hormone therapy. Following the orthotopic implantation of 4T1 mammary carcinoma cells into aged ovariectomized (OVX) mice, we evaluated the effects of calcitriol and its two analogues, PRI-2191 and PRI-2205, on metastatic spread and bone homeostasis. Calcitriol and its analogues temporarily inhibited the formation of metastases in the lungs. Unexpectedly, only mice treated with calcitriol analogues showed a deterioration of bone-related parameters, such as bone column density, marrow column density and the CaPO

Identifiants

pubmed: 31595196
doi: 10.14336/AD.2018.0921
pii: ad-10-5-977
pmc: PMC6764735
doi:

Types de publication

Journal Article

Langues

eng

Pagination

977-991

Informations de copyright

Copyright: © 2019 Anisiewicz et al.

Références

Br J Cancer. 1998 Jul;78(1):6-13
pubmed: 9662243
PLoS One. 2011 Jan 26;6(1):e16479
pubmed: 21298063
J Biol Chem. 1994 Feb 18;269(7):4794-803
pubmed: 8106449
Nat Rev Cancer. 2014 May;14(5):342-57
pubmed: 24705652
Cancer Res. 2014 Sep 1;74(17):4706-19
pubmed: 25035397
J Cell Biochem. 2014 Mar;115(3):585-95
pubmed: 24129963
Cell Commun Signal. 2017 Jun 21;15(1):23
pubmed: 28637459
Int J Mol Sci. 2015 Nov 13;16(11):27191-207
pubmed: 26580599
Endocrinology. 1994 Sep;135(3):863-9
pubmed: 8070379
J Steroid Biochem Mol Biol. 2018 Mar;177:70-76
pubmed: 29146302
Clin Breast Cancer. 2018 Feb;18(1):e25-e39
pubmed: 28802528
Free Radic Biol Med. 2013 Aug;61:72-84
pubmed: 23500899
Cancer Res. 2010 Mar 1;70(5):1835-44
pubmed: 20160035
J Steroid Biochem Mol Biol. 2013 Jul;136:289-95
pubmed: 22939886
Clin Cancer Res. 2014 Sep 1;20(17):4471-7
pubmed: 25013124
Mech Ageing Dev. 2014 Sep;140:13-22
pubmed: 25068886
Int J Cancer. 2018 Jul 15;143(2):368-382
pubmed: 29441580
Crit Rev Eukaryot Gene Expr. 2009;19(1):47-60
pubmed: 19191756
Immunotherapy. 2018 Jun;10(7):555-566
pubmed: 29852828
Mol Immunol. 2009 Feb;46(4):587-91
pubmed: 18952291
Steroids. 2004 Sep;69(10):629-35
pubmed: 15465107
Rapid Commun Mass Spectrom. 2013 Nov 15;27(21):2453-60
pubmed: 24097402
Am J Pathol. 2007 Oct;171(4):1342-51
pubmed: 17823292
Crit Rev Oncol Hematol. 2017 Apr;112:190-197
pubmed: 28325259
J Dermatol. 1990 Mar;17(3):135-42
pubmed: 2162363
Oncol Rep. 2014 Aug;32(2):491-504
pubmed: 24919507
J Steroid Biochem Mol Biol. 2013 Jul;136:171-4
pubmed: 23220095
Anticancer Res. 2013 Feb;33(2):433-44
pubmed: 23393334
JAMA. 2017 Mar 28;317(12):1234-1243
pubmed: 28350929
J Bone Miner Res. 2002 Apr;17(4):622-9
pubmed: 11918219
Arch Biochem Biophys. 2004 Nov 15;431(2):261-70
pubmed: 15488475
Biochem Biophys Res Commun. 2007 Aug 17;360(1):76-82
pubmed: 17585873
Int J Mol Sci. 2018 Jul 20;19(7):null
pubmed: 30037009
Cell Biol Int. 1999;23(7):481-7
pubmed: 10728785
Calcif Tissue Int. 2018 Feb;102(2):251-264
pubmed: 29353450
Aging Dis. 2014 Feb 16;6(1):56-75
pubmed: 25657853
Cancers (Basel). 2013 Oct 31;5(4):1355-78
pubmed: 24202449
Cancer Prev Res (Phila). 2015 Feb;8(2):120-8
pubmed: 25468832
Int J Oncol. 2018 Jan;52(1):103-126
pubmed: 29115583
Cell Physiol Biochem. 2016;40(3-4):743-756
pubmed: 27915349
Cancer Res. 1991 Apr 15;51(8):2144-50
pubmed: 2009532
Anticancer Drugs. 2007 Apr;18(4):447-57
pubmed: 17351397
J Bone Oncol. 2017 Mar 23;7:1-12
pubmed: 28413771
Mol Cancer Ther. 2015 Aug;14(8):1951-61
pubmed: 25934710
Clin Exp Immunol. 2014 Nov;178(2):364-72
pubmed: 24965738
Eur J Immunol. 2006 Dec;36(12):3090-100
pubmed: 17111352
Comput Methods Programs Biomed. 2010 Jul;99(1):88-97
pubmed: 20133007
Endocrinology. 2012 Jun;153(6):2576-87
pubmed: 22454149
Mech Ageing Dev. 2013 Mar;134(3-4):118-29
pubmed: 23403123
Bonekey Rep. 2014 Feb 05;3:495
pubmed: 24605212
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7307-11
pubmed: 7638186
J Steroid Biochem Mol Biol. 2018 Mar;177:77-82
pubmed: 29107736
Mayo Clin Proc. 2013 Jul;88(7):720-55
pubmed: 23790560
J Steroid Biochem Mol Biol. 2014 Oct;144 Pt A:65-73
pubmed: 24239860
Osteoporos Int. 2013 Dec;24(12):2929-53
pubmed: 24146095
Kidney Int. 2012 Dec;82(12):1261-70
pubmed: 22932118
Int J Oncol. 2018 Feb;52(2):337-366
pubmed: 29345296
Med Oncol. 2008;25(2):113-24
pubmed: 17973095
Breast J. 2014 Mar-Apr;20(2):174-9
pubmed: 24467395
Aging Dis. 2012 Aug;3(4):313-29
pubmed: 23185713
J Bone Miner Res. 1991 Oct;6(10):1051-7
pubmed: 1796753
Int J Clin Exp Pathol. 2015 May 01;8(5):5988-96
pubmed: 26191332
Mol Endocrinol. 2004 Sep;18(9):2208-23
pubmed: 15178742
Oncogene. 2014 Apr 17;33(16):2053-64
pubmed: 23728336
Cancer Biol Ther. 2005 Jul;4(7):740-6
pubmed: 15970685
Cancer Res. 2015 Mar 15;75(6):963-73
pubmed: 25600648
J Adv Pract Oncol. 2012 Jul;3(4):245-8
pubmed: 25031952
Cancer Res. 1995 Apr 1;55(7):1540-6
pubmed: 7882362
J Gerontol A Biol Sci Med Sci. 2011 Apr;66(4):430-6
pubmed: 21325343
Cancer Chemother Pharmacol. 2008 Oct;62(5):787-97
pubmed: 18188568
Breast Cancer Res Treat. 2012 Jul;134(2):709-17
pubmed: 22562178
BMC Cancer. 2013 Jun 18;13:294
pubmed: 23777514

Auteurs

Artur Anisiewicz (A)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Beata Filip-Psurska (B)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Agata Pawlik (A)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Anna Nasulewicz-Goldeman (A)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Tomasz Piasecki (T)

2Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences, Wroclaw, Poland.

Konrad Kowalski (K)

3Masdiag Sp. z o.o., Żeromskiego 33, Warsaw, Poland.

Magdalena Maciejewska (M)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Joanna Jarosz (J)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Joanna Banach (J)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Diana Papiernik (D)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Andrzej Mazur (A)

4Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, F-63000 Clermont-Ferrand, France.

Andrzej Kutner (A)

5Pharmaceutical Research Institute, 01-793 Warsaw, Poland.

Jeanette A Maier (JA)

6Università di Milano, Dept. Biomedical and Clinical Sciences, 20157 Milano, Italy.

Joanna Wietrzyk (J)

1Department of Experimental Oncology, Hirszfeld Institute of Immunology and Experimental Therapy, Wroclaw, Poland.

Classifications MeSH